FRONT MOL BIOSCI 潤(rùn)色咨詢(xún)

Frontiers in Molecular Biosciences

出版年份:暫無(wú)數(shù)據(jù) 年文章數(shù):2535 投稿命中率: 開(kāi)通期刊會(huì)員,數(shù)據(jù)隨心看

出版周期:暫無(wú)數(shù)據(jù) 自引率:暫無(wú)數(shù)據(jù) 審稿周期: 開(kāi)通期刊會(huì)員,數(shù)據(jù)隨心看

前往期刊查詢(xún)

投稿信息

投稿信息
審稿費(fèi)用
2950.0元/篇 (網(wǎng)友貢獻(xiàn),非官方數(shù)據(jù))
版面費(fèi)用
2818.2元/篇 (網(wǎng)友貢獻(xiàn),非官方數(shù)據(jù))
中國(guó)人發(fā)表比例
2023年中國(guó)人文章占該期刊總數(shù)量暫無(wú)數(shù)據(jù) (2022年為36.68%)
自引率
暫無(wú)數(shù)據(jù)
年文章數(shù)
2535
期刊官網(wǎng)
點(diǎn)擊查看 (點(diǎn)擊次數(shù):4726)
投稿鏈接
點(diǎn)擊查看 (點(diǎn)擊次數(shù):2516次)
作者需知
點(diǎn)擊查看 (點(diǎn)擊次數(shù):1155次)
NCBI查詢(xún)
期刊簡(jiǎn)介
稿件收錄要求
Much of contemporary investigation in the life sciences is devoted to the molecular-scale understanding of the relationships between genes and the environment — in particular, dynamic alterations in the levels, modifications, and interactions of cellular effectors, including proteins. Frontiers in Molecular Biosciences offers an international publication platform for basic as well as applied research; we encourage contributions spanning both established and emerging areas of biology. To this end, the journal draws from empirical disciplines such as structural biology, enzymology, biochemistry, and biophysics, capitalizing as well on the technological advancements that have enabled metabolomics and proteomics measurements in massively parallel throughput, and the development of robust and innovative computational biology strategies. We also recognize influences from medicine and technology, welcoming studies in molecular genetics, molecular diagnostics and therapeutics, and nanotechnology.
Our ultimate objective is the comprehensive illustration of the molecular mechanisms regulating proteins, nucleic acids, carbohydrates, lipids, and small metabolites in organisms across all branches of life.
In addition to interesting new findings, techniques, and applications, Frontiers in Molecular Biosciences will consider new testable hypotheses to inspire different perspectives and stimulate scientific dialogue. The integration of in silico, in vitro, and in vivo approaches will benefit endeavors across all domains of the life sciences.